Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 1

Status

Completed 4Terminated 1Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 2Breast 2Thoracic 1Gynecologic 1

Conditions

Colorectal Neoplasms 2Breast Neoplasms 2Ovarian Cancer Recurrent 1Lung Neoplasms 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Tocotrienols × Clear all
NCT04245865 2026-04-03

Toco-CoR

Vejle Hospital

Phase 2 Active not recruiting
83 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT04175470 2025-01-03

Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer

Vejle Hospital

Phase 2 Completed
20 enrolled
Gynecologic

Ovarian Cancer Recurrent

NCT02705300 2024-08-29

Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer

Vejle Hospital

Phase 2 Completed
70 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02909751 2021-05-20

NeoToc

Vejle Hospital

Phase 2 Completed
80 enrolled
Breast

Breast Neoplasms

NCT02644252 2021-05-03

Toco-Pulm

Vejle Hospital

Phase 3 Terminated
79 enrolled
Thoracic

Lung Neoplasms

NCT04496492 2020-08-03

TOCANNATO

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Completed
50 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡